These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori]. Jeong MH; Chung JW; Lee SJ; Ha M; Jeong SH; Na S; Na BS; Park SK; Kim YJ; Kwon KA; Ko KI; Jo Y; Hahm KB; Jung HY Korean J Gastroenterol; 2012 Jun; 59(6):401-6. PubMed ID: 22735872 [TBL] [Abstract][Full Text] [Related]
11. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282 [TBL] [Abstract][Full Text] [Related]
13. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients. Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050 [TBL] [Abstract][Full Text] [Related]
14. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. Mori H; Suzuki H; Matsuzaki J; Tsugawa H; Fukuhara S; Miyoshi S; Hirata K; Seino T; Matsushita M; Nishizawa T; Masaoka T; Kanai T United European Gastroenterol J; 2016 Jun; 4(3):380-7. PubMed ID: 27403304 [TBL] [Abstract][Full Text] [Related]
15. 'Rescue' therapies for the management of Helicobacter pylori infection. Di Mario F; Cavallaro LG; Scarpignato C Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection. Borody TJ; Pang G; Wettstein AR; Clancy R; Herdman K; Surace R; Llorente R; Ng C Aliment Pharmacol Ther; 2006 Feb; 23(4):481-8. PubMed ID: 16441468 [TBL] [Abstract][Full Text] [Related]
17. Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens. Perri F; Festa V; Clemente R; Quitadamo M; Andriulli A Aliment Pharmacol Ther; 2000 Mar; 14(3):311-6. PubMed ID: 10735924 [TBL] [Abstract][Full Text] [Related]
18. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments. Gisbert JP; Gisbert JL; Marcos S; Pajares JM Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810 [TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin. Gisbert JP; Gisbert JL; Marcos S; Olivares D; Pajares JM Aliment Pharmacol Ther; 2005 Nov; 22(10):1041-6. PubMed ID: 16268980 [TBL] [Abstract][Full Text] [Related]
20. Rifabutin-Based Triple Therapy (RHB-105) for Graham DY; Canaan Y; Maher J; Wiener G; Hulten KG; Kalfus IN Ann Intern Med; 2020 Jun; 172(12):795-802. PubMed ID: 32365359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]